BNT163b2 immunogenicity in patients with PIMS-TS/MIS-C history

Published: 21 April 2023| Version 1 | DOI: 10.17632/wg784gpd8b.1
Contributors:
, Aneta Popiel, Agnieszka Matkowska-Kocjan, Mateusz Biela, Marta Wójcik, Filip Szenborn, Katarzyna Wielgos, Ewa Pielka, Janusz Zaryczański,
, Leszek Szenborn

Description

This dataset includes the data for a prospective cohort study evaluating of Pfizer-BioNTech COVID-19 mRNA bnt163b2 vaccine (Comirnaty®) immunogenicity reactogenicity among patients with the anamnesis of paediatric inflammatory syndrome temporally associated with COVID-19 (PIMS-TS) and among healthy controls without such an anamnesis. The ethical approval was obtained from the Bioethics Committee at Wroclaw Medical University (CWN UMW BW: 313/2020 and CWN UMW BW 42/2022)

Files

Categories

Medicine, Pediatrics, Vaccine, COVID-19

Related Links

Dataset
https://doi.org/10.17632/7nh8mrznkc.3
compiles this dataset
Article
https://doi.org/10.1016/j.vaccine.2023.04.035
is source of this dataset

Licence